Show simple item record

dc.date.accessioned2010-11-08T14:20:38Zen
dc.date.available2010-11-08T14:20:38Zen
dc.date.issued2004-06-01
dc.identifier.isbn978-1-84814-706-5
dc.identifier.urihttp://hdl.handle.net/10546/115054
dc.descriptionThe US government is using bilateral and regional free-trade agreements (FTAs) to impose unnecessarily stringent intellectual property standards on developing countries that go beyond even the damaging requirements of World Trade Organisation (WTO) rules. These new higher standards favour the short-term commercial interests of US pharmaceutical companies, at the expense of public health in developing countries.en_US
dc.format.extent23en_US
dc.format.mimetypePDFen_US
dc.language.isoEnglishen_US
dc.publisherOxfam Internationalen_US
dc.relation.urlhttps://policy-practice.oxfam.org.uk/publications/undermining-access-to-medicines-comparison-of-five-us-ftas-a-technical-note-115054
dc.subjectAid
dc.titleUndermining Access to Medicines: Comparison of five US FTAs: A technical noteen_US
dc.typeBriefing noteen_US
oxfam.signoff.statusFor public use. Can be shared outside Oxfam.en_US
oxfam.subject.countryUnited Statesen_US
oxfam.subject.keywordAccess to medicinesen_US
oxfam.subject.keywordTrade policyen_US
dc.year.issuedate2004en_US
refterms.dateFOA2018-08-17T01:22:51Z


Files in this item

Thumbnail
Name:
bn-undermining-access-to-medic ...
Size:
188.6Kb
Format:
PDF
Description:
English paper

This item appears in the following Collection(s)

Show simple item record